| Characterization of progressive periodontal lesions in chronic periodontitis patients: levels of chemokines, cytokines, matrix metalloproteinase‐13, periodontal pathogens and … N Silva, N Dutzan, M Hernandez, A Dezerega, O Rivera, JC Aguillon, ... Journal of clinical periodontology 35 (3), 206-214, 2008 | 217 | 2008 |
| A new spectrophotometric method for the determination of ferrous iron in the presence of ferric iron L Herrera, P Ruiz, JC Aguillon, A Fehrmann Journal of Chemical Technology and Biotechnology 44 (3), 171-181, 1989 | 207 | 1989 |
| Immunosuppressive mechanisms of regulatory B cells D Catalán, MA Mansilla, A Ferrier, L Soto, K Oleinika, JC Aguillón, ... Frontiers in immunology 12, 611795, 2021 | 182 | 2021 |
| Levels of interferon‐gamma and transcription factor T‐bet in progressive periodontal lesions in patients with chronic periodontitis N Dutzan, R Vernal, M Hernandez, A Dezerega, O Rivera, N Silva, ... Journal of Periodontology 80 (2), 290-296, 2009 | 164 | 2009 |
| Effect of interleukin-6 receptor blockade on the balance between regulatory T cells and T helper type 17 cells in rheumatoid arthritis patients B Pesce, L Soto, F Sabugo, P Wurmann, M Cuchacovich, MN López, ... Clinical & Experimental Immunology 171 (3), 237-242, 2013 | 148 | 2013 |
| A synthetic peptide homologous to functional domain of human IL-10 down-regulates expression of MHC class I and transporter associated with antigen processing 1/2 in human … M Kurte, M López, A Aguirre, A Escobar, JC Aguillón, J Charo, CG Larsen, ... The Journal of Immunology 173 (3), 1731-1737, 2004 | 111 | 2004 |
| Tumour necrosis factor (TNF) α− 308 G/G promoter polymorphism and TNFα levels correlate with a better response to adalimumab in patients with rheumatoid arthritis M Cuchacovich, L Soto, M Edwardes, M Gutierrez, C Llanos, D Pacheco, ... Scandinavian journal of rheumatology 35 (6), 435-440, 2006 | 104 | 2006 |
| Tumour necrosis factor‐α (TNF‐α) levels and influence of− 308 TNF‐α promoter polymorphism on the responsiveness to infliximab in patients with rheumatoid arthritis M Cuchacovich, L Ferreira, M Aliste, L Soto, J Cuenca, A Cruzat, H Gatica, ... Scandinavian journal of rheumatology 33 (4), 228-232, 2004 | 102 | 2004 |
| TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients O Aravena, A Ferrier, M Menon, C Mauri, JC Aguillón, L Soto, D Catalán Arthritis research & therapy 19, 1-13, 2017 | 99 | 2017 |
| The role of interleukin-6 signalling and its therapeutic blockage in skewing the T cell balance in rheumatoid arthritis K Schinnerling, JC Aguillón, D Catalán, L Soto Clinical & experimental immunology 189 (1), 12-20, 2017 | 95 | 2017 |
| Tolerogenic dendritic cells for reprogramming of lymphocyte responses in autoimmune diseases P García-González, G Ubilla-Olguín, D Catalán, K Schinnerling, ... Autoimmunity reviews 15 (11), 1071-1080, 2016 | 87 | 2016 |
| Anti-TNF therapy in patients with rheumatoid arthritis decreases Th1 and Th17 cell populations and expands IFN-γ-producing NK cell and regulatory T cell subsets O Aravena, B Pesce, L Soto, N Orrego, F Sabugo, P Wurmann, MC Molina, ... Immunobiology 216 (12), 1256-1263, 2011 | 82 | 2011 |
| Genetic polymorphism at position-308 in the promoter region of the tumor necrosis factor (TNF): implications of its allelic distribution on susceptibility or resistance to … J Cuenca, CA Pérez, AJ Aguirre, I Schiattino, JC Aguillón Biological Research 34 (3-4), 237-241, 2001 | 82 | 2001 |
| Humanized mouse models of rheumatoid arthritis for studies on immunopathogenesis and preclinical testing of cell-based therapies K Schinnerling, C Rosas, L Soto, R Thomas, JC Aguillón Frontiers in immunology 10, 433599, 2019 | 79 | 2019 |
| Could single-nucleotide polymorphisms (SNPs) affecting the tumour necrosis factor promoter be considered as part of rheumatoid arthritis evolution? JC Aguillón, A Cruzat, O Aravena, L Salazar, C Llanos, M Cuchacovich Immunobiology 211 (1-2), 75-84, 2006 | 78 | 2006 |
| B cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and FcγRIIb, which are modulated by anti-tumor necrosis factor therapy D Catalán, O Aravena, F Sabugo, P Wurmann, L Soto, AM Kalergis, ... Arthritis research & therapy 12, 1-11, 2010 | 77 | 2010 |
| The −308 polymorphism in the tumour necrosis factor (TNF) gene promoter region and ex vivo lipopolysaccharide‐induced TNF expression and cytotoxic activity in … J Cuenca, M Cuchacovich, C Perez, L Ferreira, A Aguirre, I Schiattino, ... Rheumatology 42 (2), 308-313, 2003 | 74 | 2003 |
| Gene expression profiling of human monocyte-derived dendritic cells–searching for molecular regulators of tolerogenicity K Schinnerling, P García-González, JC Aguillón Frontiers in immunology 6, 163888, 2015 | 66 | 2015 |
| The role of regulatory T lymphocytes in the induced immune response mediated by biological vaccines M Lopez, R Aguilera, C Perez, A Mendoza-Naranjo, C Pereda, M Ramirez, ... Immunobiology 211 (1-2), 127-136, 2006 | 63 | 2006 |
| Ex vivo lipopolysaccharide (LPS)-induced TNF-alpha, IL-1beta, IL-6 and PGE2 secretion in whole blood from Type 1 diabetes mellitus patients with or without aggressive periodontitis AV Araya, V Pavez, C Perez, F Gonzalez, A Colombo, A Aguirre, ... European cytokine network 14 (3), 128-133, 2003 | 61 | 2003 |
diego catalanUniversidad de ChileVerified email at med.uchile.cl
